We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+8.07%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$323B
AUM Growth
+$22.5B
Cap. Flow
-$250M
Cap. Flow %
-0.08%
Top 10 Hldgs %
14.98%
Holding
4,059
New
217
Increased
1,727
Reduced
1,816
Closed
179

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$452M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$359M
3
ACN icon
Accenture
ACN
+$329M
4
BDX icon
Becton Dickinson
BDX
+$318M
5
KO icon
Coca-Cola
KO
+$269M

Sector Composition

Rank Sector Weight
1 Technology 23.79%
2 Financials 11.74%
3 Healthcare 10.79%
4 Consumer Discretionary 8.84%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGI
3926
DELISTED
MoneyGram International, Inc. New
MGI
-12,370
Closed -$81K
TCRR
3927
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-17,995
Closed -$398K
JNCE
3928
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-12,000
Closed -$123K
PRVB
3929
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-28,330
Closed -$298K
ALBO
3930
DELISTED
Albireo Pharma Inc
ALBO
-13,361
Closed -$471K
ELVT
3931
DELISTED
Elevate Credit, Inc.
ELVT
-16,890
Closed -$49K
LCI
3932
DELISTED
Lannett Company, Inc.
LCI
-42,255
Closed -$892K
MNRL
3933
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
-226,020
Closed -$3.31M
ECOM
3934
DELISTED
CHANNELADVISOR CORPORATION
ECOM
-36,126
Closed -$851K
CCXI
3935
DELISTED
ChemoCentryx, Inc.
CCXI
-32,577
Closed -$1.67M
IEA
3936
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-38,910
Closed -$634K
RDUS
3937
DELISTED
Radius Health, Inc.
RDUS
-34,764
Closed -$725K
ENIA
3938
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
-17,563
Closed -$149K
RESN
3939
DELISTED
Resonant Inc.
RESN
-45,046
Closed -$191K
FMO
3940
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
-103,484
Closed -$1.04M
CPLG
3941
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
-32,562
Closed -$294K
RRD
3942
DELISTED
RR Donnelley & Sons Co.
RRD
-28,569
Closed -$116K
DRNA
3943
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-22,063
Closed -$564K
ENBL
3944
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
-110,427
Closed -$716K
CVA
3945
DELISTED
Covanta Holding Corporation
CVA
-55,178
Closed -$765K
JTD
3946
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
-10,350
Closed -$156K
SBBP
3947
DELISTED
Strongbridge Biopharma plc.
SBBP
-26,179
Closed -$72K
IEC
3948
DELISTED
IEC Electronics Corp.
IEC
-20,381
Closed -$245K
SNR
3949
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
-35,323
Closed -$220K
SWI
3950
DELISTED
SolarWinds Corporation Common Stock
SWI
-19,733
Closed -$363K

Similar funds

Ameriprise's Q2 2021 Portfolio in Review

As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ameriprise's Q2 2021 filing shows 217 new, 1,727 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
  • Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
  • Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
  • Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
  • Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
  • Ameriprise opened 217 new positions and closed 179 in Q2 2021.
  • Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.

Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.